Atlas Trials

Efficacy and Tolerability of Test Product Versus Cysteamine 5% in Treatment of Facial Epidermal Melasma

Clinical trial NCT06278948 · UNKNOWN

Trial details

NCT number
NCT06278948
Sponsor
Cosmetique Active International
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Melasma
Start date
2023-10-06
Primary completion
2024-06-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.